Vertigo and Dizziness After Coronavirus Disease-2019 Vaccination: A Nationwide Analysis.

IF 1 4区 医学 Q3 OTORHINOLARYNGOLOGY
Sang Hoon Kim, Dong Keon Yon, Yong Sung Choi, Jinseok Lee, Ki-Ho Park, Young Ju Lee, Dong Choon Park, Sung Soo Kim, Hwa Sung Rim, Seung Geun Yeo
{"title":"Vertigo and Dizziness After Coronavirus Disease-2019 Vaccination: A Nationwide Analysis.","authors":"Sang Hoon Kim,&nbsp;Dong Keon Yon,&nbsp;Yong Sung Choi,&nbsp;Jinseok Lee,&nbsp;Ki-Ho Park,&nbsp;Young Ju Lee,&nbsp;Dong Choon Park,&nbsp;Sung Soo Kim,&nbsp;Hwa Sung Rim,&nbsp;Seung Geun Yeo","doi":"10.5152/iao.2023.22937","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Side effects occurring after COVID-19 vaccination can include vertigo and dizziness. Despite its high incidence, few studies to date have assessed dizziness/vertigo after vaccination. The present study investigated the incidence of dizziness/vertigo after COVID-19 vaccination in South Korea.</p><p><strong>Methods: </strong>Adverse reactions to COVID-19 vaccination reported to the Korea Disease Control and Prevention Agency from February 26, 2021, to July 31, 2022 (week 74) were analyzed. The incidence rates of dizziness/vertigo in subjects vaccinated with 5 COVID-19 vaccines, AZD1222 (AstraZeneca), BNT162b2 (Pfizer-BioNTech), JNJ-78436735 (Janssen), mRNA-1273 (Moderna), and NVX-CoV2373 (Novavax), were determined.</p><p><strong>Results: </strong>A total of 126 725 952 doses of COVID-19 vaccine were administered, with 473 755 suspected adverse reactions (374 per 100 000 vaccinations) reported. Vertigo/dizziness was reported after the administration of 68 759 doses, or 54.3 per 100 000 vaccinations, making it the third most common adverse reaction after headache and muscle pain.</p><p><strong>Conclusion: </strong>Dizziness/vertigo was generally a mild adverse reaction after COVID-19 vaccination, but it was the third most common adverse reaction in Korea. Studies are necessary to clarify the causal relationship between vaccination and dizziness/vertigo and to prepare subjects for this possible adverse reaction.</p>","PeriodicalId":54793,"journal":{"name":"Journal of International Advanced Otology","volume":"19 3","pages":"228-233"},"PeriodicalIF":1.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9a/bd/jiao-19-3-228.PMC10331640.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of International Advanced Otology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5152/iao.2023.22937","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Side effects occurring after COVID-19 vaccination can include vertigo and dizziness. Despite its high incidence, few studies to date have assessed dizziness/vertigo after vaccination. The present study investigated the incidence of dizziness/vertigo after COVID-19 vaccination in South Korea.

Methods: Adverse reactions to COVID-19 vaccination reported to the Korea Disease Control and Prevention Agency from February 26, 2021, to July 31, 2022 (week 74) were analyzed. The incidence rates of dizziness/vertigo in subjects vaccinated with 5 COVID-19 vaccines, AZD1222 (AstraZeneca), BNT162b2 (Pfizer-BioNTech), JNJ-78436735 (Janssen), mRNA-1273 (Moderna), and NVX-CoV2373 (Novavax), were determined.

Results: A total of 126 725 952 doses of COVID-19 vaccine were administered, with 473 755 suspected adverse reactions (374 per 100 000 vaccinations) reported. Vertigo/dizziness was reported after the administration of 68 759 doses, or 54.3 per 100 000 vaccinations, making it the third most common adverse reaction after headache and muscle pain.

Conclusion: Dizziness/vertigo was generally a mild adverse reaction after COVID-19 vaccination, but it was the third most common adverse reaction in Korea. Studies are necessary to clarify the causal relationship between vaccination and dizziness/vertigo and to prepare subjects for this possible adverse reaction.

Abstract Image

Abstract Image

Abstract Image

冠状病毒-2019疫苗接种后的眩晕和头晕:一项全国性分析。
背景:COVID-19疫苗接种后发生的副作用包括眩晕和头晕。尽管发病率很高,但迄今为止很少有研究评估接种疫苗后的头晕/眩晕。本研究调查了韩国COVID-19疫苗接种后头晕/眩晕的发生率。方法:分析2021年2月26日至2022年7月31日(第74周)向韩国疾病管理本部报告的COVID-19疫苗接种不良反应。测定5种COVID-19疫苗AZD1222(阿斯利康)、BNT162b2(辉瑞- biontech)、JNJ-78436735(杨森)、mRNA-1273 (Moderna)和NVX-CoV2373 (Novavax)接种者的头晕/眩晕发生率。结果:共接种新冠肺炎疫苗126 725 952剂,报告疑似不良反应473 755例(每10万次接种374例)。在接种68759剂疫苗后报告了眩晕/头晕,即每10万次接种54.3次,使其成为仅次于头痛和肌肉疼痛的第三大常见不良反应。结论:冠状病毒疫苗接种后的头晕/眩晕通常是一种轻微的不良反应,但在韩国是第三常见的不良反应。有必要进行研究,以澄清疫苗接种与头晕/眩晕之间的因果关系,并为可能出现的不良反应做好准备。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.80
自引率
0.00%
发文量
94
审稿时长
6-12 weeks
期刊介绍: The Journal of International Advanced Otology (IAO – Citation Abbreviation: J Int Adv Otol) is an open access double-blind peer-reviewed, international publication. The Journal of International Advanced Otology is fully sponsored and owned by the European Academy of Otology and Neurotology and the Politzer Society. The Journal of International Advanced Otology is published 3 times per year on April, August, December and its publication language is English. The scope of the Journal is limited with otology, neurotology, audiology (excluding linguistics) and skull base medicine. The Journal of International Advanced Otology aims to publish manuscripts at the highest clinical and scientific level. IAO publishes original articles in the form of clinical and basic research, review articles, short reports and a limited number of case reports. Controversial patient discussions, communications on emerging technology, and historical issues will also be considered for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书